Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study-Reference-Cited by-同舟云学术

Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study

Published:2013-01 Issue: Volume:64 Page:197-204
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Winterer Georg,Gallinat Jürgen,Brinkmeyer Jürgen,Musso Francesco,Kornhuber Johannes,Thuerauf Norbert,Rujescu Dan,Favis Reyna,Sun Yu,Franc Monique A.,Ouwerkerk-Mahadevan Sivi,Janssens Luc,Timmers Maarten,Streffer Johannes R.

Funder

Janssen Research and Development, Janssen Pharmaceutica N.V.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference80 articles.

1. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics;Adler;Biol. Psychiatry,1992

2. Normalization of auditory physiology by cigarette smoking in schizophrenic patients;Adler;Am. J. Psychiatry,1993

3. Schizophrenia, sensory gating, and nicotinic receptors;Adler;Schizophr. Bull.,1998

4. Positive and negative modulation of nicotinic receptors;Arias;Adv. Protein Chem. Struct. Biol.,2010

5. Smoking, quitting, and psychiatric disease: a review;Aubin;Neurosci. Biobehav. Rev.,2012

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural mechanisms of α7 nicotinic receptor allosteric modulation and activation;Cell;2024-02

2. Nicotinic Receptors of the Neuronal and Non-neuronal Cholinergic Systems as Therapeutic Targets: Opportunities and Limitations;Ion Channels as Targets in Drug Discovery;2024

3. Selective Buchwald–Hartwig arylation of C-amino-1,2,4-triazoles and other coordinating aminoheterocycles enabled by bulky NHC ligands and TPEDO activator;Inorganic Chemistry Frontiers;2023

4. Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective;Pharmacological Research;2022-02

5. The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial;European Neuropsychopharmacology;2021-10